Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Dec;61(6):592-6.

A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium

  • PMID: 7903505
Clinical Trial

A comparison of the onset time, duration of action, and fade characteristics of atracurium and vecuronium

M Haines. AANA J. 1993 Dec.

Abstract

The speed of onset (T1 = 95% twitch depression) and the duration of action (T1 = 25% control) of equipotent doses of atracurium 0.5 mg/kg and vecuronium 0.1 mg/kg were compared in 21 ASA physical status I and II adult patients. Train-of-four (TOF) ratios (height of T4/T1) were also compared with the first response in the TOF recovered to 25% and 50% control, respectively. Neuromuscular function was measured by the Datex NMT 221 electromyograph at the hypothenar muscles. No significant difference was seen in the onset of action of these two drugs, but a significantly shorter duration of action was observed with vecuronium (P < 0.5). Vecuronium was also found to exhibit significantly more TOF fade on offset of block than atracurium. Vecuronium may offer a distinct advantage over atracurium when a nondepolarizer is required for a relatively short clinical case. However, it appears that vecuronium causes more TOF fade during recovery from neuromuscular blockade than atracurium.

PubMed Disclaimer